Blood-stasis-dissipating blood-circulation-promoting fast fracture-setting medicament

Abstract

The present invention provides a rapid coaptation medicine 'jiegurushendan' with promoting blood circulation function by removing blood stasis which belongs to plarmacy technology field. The jiegurushendan is a hereditary secret formula of meng's coaptation. The medicine is prepared from Chinese traditional medicines including 15-8 parts dragon's blood, 4-8 parts szechuan lovage rhizome, 4-8 parts olibanum, 4-8 parts myrrh, 4-8 parts angelica, 2-5 parts ephedra, 4-8 parts tuchong, 1-5 parts white paeony root, 15-8 parts sanchi, 4-8 parts fired pyrite, 6-10 parts danshen root, 15-8 parts deer's horn, 1-3 parts vermilion, 1-3 parts borneol, 4-8 parts liquorice, 1-3 parts saffron, 0.1-0.2 parts muskiness. The preparing technology is: weighing as formulation, then pulverizating into fine powder. The medicine treats mainly in: all fractures, injuries from falls, trauma edema pain, blood stasis condensation, injury of tendon and muscle. The medicine has merits of low amount medicine, low cost and obvious effect, and has advantages of positive curing effect, simply processing, non-toxic side effect, rapid stop-pain and coaptation.

Description

technical field [0001] The invention belongs to the technical field of pharmacy, and in particular relates to a medicine for fast bone setting, the international patent classification number: A61P19 / 08. Background technique [0002] Fracture is a common surgical disease. Clinically, surgical treatment or butt joint fixation is generally adopted. In traditional Chinese medicine, osteosynthesis is external application or oral Chinese medicine after reduction or butt joint. There are many kinds of traditional Chinese medicines for the treatment of fractures in the market, but the curative effect is relatively poor, the course of treatment is relatively long, and the price is high, so that the patient cannot relieve the pain quickly, and has to bear the economic burden again. [0003] The time-honored Chinese brand "Meng's Bone Synthesis" has been passed down for more than 200 years. Meng Xianduo, the sixth-generation successor of Meng's Bone Synthesis, and Meng Qingshuang, the ...

AI Technical Summary

Problems solved by technology

At present, there are many kinds of traditional Chinese medicines for treating fractures in the market, but the curative effect is relatively poor, the course of treatment is relatively long, and the price is high, so that the patients cannot relieve the pain quickly, and they have to bear the financial burden.